WO2001030972A3 - Regulation of gene expression by neuroleptic agents - Google Patents

Regulation of gene expression by neuroleptic agents Download PDF

Info

Publication number
WO2001030972A3
WO2001030972A3 PCT/US2000/029690 US0029690W WO0130972A3 WO 2001030972 A3 WO2001030972 A3 WO 2001030972A3 US 0029690 W US0029690 W US 0029690W WO 0130972 A3 WO0130972 A3 WO 0130972A3
Authority
WO
WIPO (PCT)
Prior art keywords
regulation
gene expression
neuroleptic agents
neuroleptic
agents
Prior art date
Application number
PCT/US2000/029690
Other languages
French (fr)
Other versions
WO2001030972A2 (en
Inventor
Elizabeth A Thomas
J Gregor Sutcliffe
Thomas M Pribyl
Brian Hilbush
Karl W Hasel
Original Assignee
Digital Gene Tech Inc
Elizabeth A Thomas
J Gregor Sutcliffe
Thomas M Pribyl
Brian Hilbush
Karl W Hasel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Digital Gene Tech Inc, Elizabeth A Thomas, J Gregor Sutcliffe, Thomas M Pribyl, Brian Hilbush, Karl W Hasel filed Critical Digital Gene Tech Inc
Priority to AU13498/01A priority Critical patent/AU1349801A/en
Priority to EP00975448A priority patent/EP1226152A2/en
Priority to CA002389110A priority patent/CA2389110A1/en
Priority to MXPA02004241A priority patent/MXPA02004241A/en
Priority to JP2001533956A priority patent/JP2003533970A/en
Publication of WO2001030972A2 publication Critical patent/WO2001030972A2/en
Publication of WO2001030972A3 publication Critical patent/WO2001030972A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Polynucleotides, polypeptides, kits and methods are provided related to genes expressed in the central nervous system that are regulated by neuroleptics.
PCT/US2000/029690 1999-10-26 2000-10-26 Regulation of gene expression by neuroleptic agents WO2001030972A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU13498/01A AU1349801A (en) 1999-10-26 2000-10-26 Regulation of gene expression by neuroleptic agents
EP00975448A EP1226152A2 (en) 1999-10-26 2000-10-26 Regulation of gene expression by neuroleptic agents
CA002389110A CA2389110A1 (en) 1999-10-26 2000-10-26 Regulation of gene expression by neuroleptic agents
MXPA02004241A MXPA02004241A (en) 1999-10-26 2000-10-26 Regulation of gene expression by neuroleptic agents.
JP2001533956A JP2003533970A (en) 1999-10-26 2000-10-26 Regulation of gene expression by neuroleptics

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16137999P 1999-10-26 1999-10-26
US60/161,379 1999-10-26

Publications (2)

Publication Number Publication Date
WO2001030972A2 WO2001030972A2 (en) 2001-05-03
WO2001030972A3 true WO2001030972A3 (en) 2002-05-10

Family

ID=22580950

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/029690 WO2001030972A2 (en) 1999-10-26 2000-10-26 Regulation of gene expression by neuroleptic agents

Country Status (6)

Country Link
EP (1) EP1226152A2 (en)
JP (1) JP2003533970A (en)
AU (1) AU1349801A (en)
CA (1) CA2389110A1 (en)
MX (1) MXPA02004241A (en)
WO (1) WO2001030972A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960439B2 (en) 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
EP1573024A4 (en) 2001-04-10 2007-08-29 Agensys Inc Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
WO2003040404A1 (en) 2001-11-09 2003-05-15 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EST [online] WASHINGTON UNIVERSITY SCHOOL OF MEDICINE; 18 February 1997 (1997-02-18), MARRA ET AL.: "WashU-HHMI mouse EST project", XP002942528, accession no. STN Database accession no. AA144003 *
DATABASE GENEMBL [online] 15 August 1999 (1999-08-15), OKA ET AL.: "The role of murine seine protease HTRA in osteogenesis", XP002942527, accession no. STN Database accession no. AF172994 *

Also Published As

Publication number Publication date
JP2003533970A (en) 2003-11-18
EP1226152A2 (en) 2002-07-31
MXPA02004241A (en) 2002-10-17
CA2389110A1 (en) 2001-05-03
WO2001030972A2 (en) 2001-05-03
AU1349801A (en) 2001-05-08

Similar Documents

Publication Publication Date Title
MX9705039A (en) Programmed cell death genes and proteins.
ZA200006594B (en) DSRNA-mediated regulation of gene expression in plants.
MXPA02004882A (en) Plant developmental genes.
AU2002343557A1 (en) Substituted aryl 1,4-pyrazine derivatives
AU2086199A (en) Plant uridine diphosphate-glucose dehydrogenase genes, proteins, and uses thereof
WO2002008409A3 (en) Methods for the replacement, translocation and stacking of dna in eukaryotic genomes
WO2000066730A3 (en) Laminin 2 and methods for its use
WO2004024940A3 (en) Rna-mediated gene modulation
AU2003234198A1 (en) Novel genes, compositions, and methods for modulating the unfolded protein response
JP2004500380A5 (en)
WO2001049721A3 (en) Bacterial genes and proteins that are essential for cell viability and their uses
WO2001030972A3 (en) Regulation of gene expression by neuroleptic agents
TW200503717A (en) Substituted 1,4-pyrazine derivatives
CA2331781A1 (en) De novo dna cytosine methyltransferase genes, polypeptides and uses thereof
AU2001256232A1 (en) Genes isolated from dendritic cells, gene products and methods employing the same
WO2001029179A3 (en) Regulation of gene expression by neuromodulators
WO2003057825A3 (en) Gene expression patterns in response to atypical and typical neuroleptic agents in the central nervous system
WO2001007431A3 (en) Benzothiophene derivatives
ZA988637B (en) Methods for regulating trkA expression.
WO2000061729A3 (en) Regulation of the expression of transcriptional repressor genes using nucleic acid molecules
EP1148139A4 (en) Variant luciferase, variant luciferase gene, novel recombinant dna and process for producing variant luciferase
AU2003250033A1 (en) Genes associated with schizophrenia, adhd and bipolar disorders
WO2002031114A3 (en) Gene expression modulated in ileitis
AU2001296451A1 (en) Gene expression in the central nervous system regulated by neuroleptic agents
AU2750197A (en) Dna replication-regulating genes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2001 533956

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/004241

Country of ref document: MX

Ref document number: 2389110

Country of ref document: CA

Ref document number: 13498/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000975448

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000975448

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642